Granzyme B |
Cytotoxic T lymphocyte mediated tumour cell apoptosis |
Zhu et al. [90] |
Perforin |
Takes part in NK cell mediated oral cancer cell destruction |
Hadler-Olsen et al. [91] |
FasL |
Mediator of immune privilege in OSCC |
Fang et al. [92] |
Fas (CD95) |
Considered a prognostic marker of OSCC |
Peter et al. [93] |
TNF-α |
Promotes oral cancer growth and pain |
Salvo et al. [94] |
TNFR1 (CD120a) |
Related to oral cancer pain and inflammation |
Scheff et al. [95] |
FADD |
Prognostic implication in OSCC |
Gonzales-Moles et al. [96] |
Apaf1 |
Helps in the formation of apoptosome |
Dwivedi et al. [97] |
Bcl-2 |
Altered expression results in an increase in malignant transformation potential |
Juneja et al. [98] |
Bcl-2a1 (Bfl-1) and Cytochrome C |
Promotes apoptosis in OSCC |
Zheng et al. [99] |
Mcl-1 |
Overexpression of anti-apoptotic factor Mcl-1 leads to progression of OSCC |
Sulkshane et al. [100] |
Bcl-xL |
Causes resistance to chemotherapeutic drugs |
Alam et al. [101] |
Bcl-w |
Cooperates with oncogene activation in the development and progression of OSCC |
Hartman et al. [102] |
BH3 |
Anti-anti-apoptotic functions in OSCC |
Carter et al. [103] |